Quote:

---

It can take as long or as short as an arbitration can take. See my point? The Amarex situation could be over in a week or in years or anywhere in between.

---

Risk of protracted arbitration for Amarex and therefore NSF is the ongoing hit to their credibility or at the very least, the doubt that is sewn about their practices on an ongoing basis. For Cytodyn, it is a matter of whether any partners or suitors would be put off by it being an open item (in that case it can be settled rather quickly by giving on enough of its financial expectations to accomplish it)